Click for best price
Pharma Ophthalmic Market Size, Share 2022
This report contains market size and forecasts of Pharma Ophthalmic in global, including the following market information:
Global Pharma Ophthalmic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pharma Ophthalmic Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Pharma Ophthalmic companies in 2021 (%)
The global Pharma Ophthalmic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Retinal disorders drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pharma Ophthalmic include Novartis, Allergan, Roche, Valeant, Regeneron, Santen, Bayer, Pfizer and Senju and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pharma Ophthalmic manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharma Ophthalmic Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pharma Ophthalmic Market Segment Percentages, by Type, 2021 (%)
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Other ophthalmic drugs
Global Pharma Ophthalmic Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pharma Ophthalmic Market Segment Percentages, by Application, 2021 (%)
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications
Global Pharma Ophthalmic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Pharma Ophthalmic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharma Ophthalmic revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pharma Ophthalmic revenues share in global market, 2021 (%)
Key companies Pharma Ophthalmic sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Pharma Ophthalmic sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
| Report Attributes |
Report Details |
| Report Title |
Pharma Ophthalmic Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
75 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharma Ophthalmic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharma Ophthalmic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharma Ophthalmic Overall Market Size
2.1 Global Pharma Ophthalmic Market Size: 2021 VS 2028
2.2 Global Pharma Ophthalmic Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Pharma Ophthalmic Sales: 2017-2028
3 Company Landscape
3.1 Top Pharma Ophthalmic Players in Global Market
3.2 Top Global Pharma Ophthalmic Companies Ranked by Revenue
3.3 Global Pharma Ophthalmic Revenue by Companies
3.4 Global Pharma Ophthalmic Sales by Companies
3.5 Global Pharma Ophthalmic Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Pharma Ophthalmic Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Pharma Ophthalmic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pharma Ophthalmic Players in Global Market
3.8.1 List of Global Tier 1 Pharma Ophthalmic Companies
3.8.2 List of Global Tier 2 and Tier 3 Pharma Ophthalmic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharma Ophthalmic Market Size Markets, 2021 & 2028
4.1.2 Retinal disorders drugs
4.1.3 Allergic, inflammatory and infective drugs
4.1.4 Glaucoma drugs
4.1.5 Dry eye drugs
4.1.6 Other ophthalmic drugs
4.2 By Type - Global Pharma Ophthalmic Revenue & Forecasts
4.2.1 By Type - Global Pharma Ophthalmic Revenue, 2017-2022
4.2.2 By Type - Global Pharma Ophthalmic Revenue, 2023-2028
4.2.3 By Type - Global Pharma Ophthalmic Revenue Market Share, 2017-2028
4.3 By Type - Global Pharma Ophthalmic Sales & Forecasts
4.3.1 By Type - Global Pharma Ophthalmic Sales, 2017-2022
4.3.2 By Type - Global Pharma Ophthalmic Sales, 2023-2028
4.3.3 By Type - Global Pharma Ophthalmic Sales Market Share, 2017-2028
4.4 By Type - Global Pharma Ophthalmic Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Pharma Ophthalmic Market Size, 2021 & 2028
5.1.2 Glaucoma
5.1.3 Dry eye syndrome
5.1.4 Retinal diseases
5.1.5 Other ophthalmic indications
5.2 By Application - Global Pharma Ophthalmic Revenue & Forecasts
5.2.1 By Application - Global Pharma Ophthalmic Revenue, 2017-2022
5.2.2 By Application - Global Pharma Ophthalmic Revenue, 2023-2028
5.2.3 By Application - Global Pharma Ophthalmic Revenue Market Share, 2017-2028
5.3 By Application - Global Pharma Ophthalmic Sales & Forecasts
5.3.1 By Application - Global Pharma Ophthalmic Sales, 2017-2022
5.3.2 By Application - Global Pharma Ophthalmic Sales, 2023-2028
5.3.3 By Application - Global Pharma Ophthalmic Sales Market Share, 2017-2028
5.4 By Application - Global Pharma Ophthalmic Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Pharma Ophthalmic Market Size, 2021 & 2028
6.2 By Region - Global Pharma Ophthalmic Revenue & Forecasts
6.2.1 By Region - Global Pharma Ophthalmic Revenue, 2017-2022
6.2.2 By Region - Global Pharma Ophthalmic Revenue, 2023-2028
6.2.3 By Region - Global Pharma Ophthalmic Revenue Market Share, 2017-2028
6.3 By Region - Global Pharma Ophthalmic Sales & Forecasts
6.3.1 By Region - Global Pharma Ophthalmic Sales, 2017-2022
6.3.2 By Region - Global Pharma Ophthalmic Sales, 2023-2028
6.3.3 By Region - Global Pharma Ophthalmic Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Pharma Ophthalmic Revenue, 2017-2028
6.4.2 By Country - North America Pharma Ophthalmic Sales, 2017-2028
6.4.3 US Pharma Ophthalmic Market Size, 2017-2028
6.4.4 Canada Pharma Ophthalmic Market Size, 2017-2028
6.4.5 Mexico Pharma Ophthalmic Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Pharma Ophthalmic Revenue, 2017-2028
6.5.2 By Country - Europe Pharma Ophthalmic Sales, 2017-2028
6.5.3 Germany Pharma Ophthalmic Market Size, 2017-2028
6.5.4 France Pharma Ophthalmic Market Size, 2017-2028
6.5.5 U.K. Pharma Ophthalmic Market Size, 2017-2028
6.5.6 Italy Pharma Ophthalmic Market Size, 2017-2028
6.5.7 Russia Pharma Ophthalmic Market Size, 2017-2028
6.5.8 Nordic Countries Pharma Ophthalmic Market Size, 2017-2028
6.5.9 Benelux Pharma Ophthalmic Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Pharma Ophthalmic Revenue, 2017-2028
6.6.2 By Region - Asia Pharma Ophthalmic Sales, 2017-2028
6.6.3 China Pharma Ophthalmic Market Size, 2017-2028
6.6.4 Japan Pharma Ophthalmic Market Size, 2017-2028
6.6.5 South Korea Pharma Ophthalmic Market Size, 2017-2028
6.6.6 Southeast Asia Pharma Ophthalmic Market Size, 2017-2028
6.6.7 India Pharma Ophthalmic Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Pharma Ophthalmic Revenue, 2017-2028
6.7.2 By Country - South America Pharma Ophthalmic Sales, 2017-2028
6.7.3 Brazil Pharma Ophthalmic Market Size, 2017-2028
6.7.4 Argentina Pharma Ophthalmic Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pharma Ophthalmic Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Pharma Ophthalmic Sales, 2017-2028
6.8.3 Turkey Pharma Ophthalmic Market Size, 2017-2028
6.8.4 Israel Pharma Ophthalmic Market Size, 2017-2028
6.8.5 Saudi Arabia Pharma Ophthalmic Market Size, 2017-2028
6.8.6 UAE Pharma Ophthalmic Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Pharma Ophthalmic Major Product Offerings
7.1.4 Novartis Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Pharma Ophthalmic Major Product Offerings
7.2.4 Allergan Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.2.5 Allergan Key News
7.3 Roche
7.3.1 Roche Corporate Summary
7.3.2 Roche Business Overview
7.3.3 Roche Pharma Ophthalmic Major Product Offerings
7.3.4 Roche Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.3.5 Roche Key News
7.4 Valeant
7.4.1 Valeant Corporate Summary
7.4.2 Valeant Business Overview
7.4.3 Valeant Pharma Ophthalmic Major Product Offerings
7.4.4 Valeant Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.4.5 Valeant Key News
7.5 Regeneron
7.5.1 Regeneron Corporate Summary
7.5.2 Regeneron Business Overview
7.5.3 Regeneron Pharma Ophthalmic Major Product Offerings
7.5.4 Regeneron Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.5.5 Regeneron Key News
7.6 Santen
7.6.1 Santen Corporate Summary
7.6.2 Santen Business Overview
7.6.3 Santen Pharma Ophthalmic Major Product Offerings
7.6.4 Santen Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.6.5 Santen Key News
7.7 Bayer
7.7.1 Bayer Corporate Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Pharma Ophthalmic Major Product Offerings
7.7.4 Bayer Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.7.5 Bayer Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Pharma Ophthalmic Major Product Offerings
7.8.4 Pfizer Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 Senju
7.9.1 Senju Corporate Summary
7.9.2 Senju Business Overview
7.9.3 Senju Pharma Ophthalmic Major Product Offerings
7.9.4 Senju Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.9.5 Senju Key News
7.10 Akorn
7.10.1 Akorn Corporate Summary
7.10.2 Akorn Business Overview
7.10.3 Akorn Pharma Ophthalmic Major Product Offerings
7.10.4 Akorn Pharma Ophthalmic Sales and Revenue in Global (2017-2022)
7.10.5 Akorn Key News
8 Global Pharma Ophthalmic Production Capacity, Analysis
8.1 Global Pharma Ophthalmic Production Capacity, 2017-2028
8.2 Pharma Ophthalmic Production Capacity of Key Manufacturers in Global Market
8.3 Global Pharma Ophthalmic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pharma Ophthalmic Supply Chain Analysis
10.1 Pharma Ophthalmic Industry Value Chain
10.2 Pharma Ophthalmic Upstream Market
10.3 Pharma Ophthalmic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pharma Ophthalmic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pharma Ophthalmic in Global Market
Table 2. Top Pharma Ophthalmic Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Pharma Ophthalmic Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Pharma Ophthalmic Revenue Share by Companies, 2017-2022
Table 5. Global Pharma Ophthalmic Sales by Companies, (K Pcs), 2017-2022
Table 6. Global Pharma Ophthalmic Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Pharma Ophthalmic Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers Pharma Ophthalmic Product Type
Table 9. List of Global Tier 1 Pharma Ophthalmic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharma Ophthalmic Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pharma Ophthalmic Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Pharma Ophthalmic Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Pharma Ophthalmic Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Pharma Ophthalmic Sales (K Pcs), 2017-2022
Table 15. By Type - Global Pharma Ophthalmic Sales (K Pcs), 2023-2028
Table 16. By Application ? Global Pharma Ophthalmic Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Pharma Ophthalmic Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Pharma Ophthalmic Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Pharma Ophthalmic Sales (K Pcs), 2017-2022
Table 20. By Application - Global Pharma Ophthalmic Sales (K Pcs), 2023-2028
Table 21. By Region ? Global Pharma Ophthalmic Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Pharma Ophthalmic Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Pharma Ophthalmic Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Pharma Ophthalmic Sales (K Pcs), 2017-2022
Table 25. By Region - Global Pharma Ophthalmic Sales (K Pcs), 2023-2028
Table 26. By Country - North America Pharma Ophthalmic Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Pharma Ophthalmic Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Pharma Ophthalmic Sales, (K Pcs), 2017-2022
Table 29. By Country - North America Pharma Ophthalmic Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe Pharma Ophthalmic Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Pharma Ophthalmic Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Pharma Ophthalmic Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe Pharma Ophthalmic Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia Pharma Ophthalmic Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Pharma Ophthalmic Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Pharma Ophthalmic Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia Pharma Ophthalmic Sales, (K Pcs), 2023-2028
Table 38. By Country - South America Pharma Ophthalmic Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Pharma Ophthalmic Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Pharma Ophthalmic Sales, (K Pcs), 2017-2022
Table 41. By Country - South America Pharma Ophthalmic Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa Pharma Ophthalmic Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Pharma Ophthalmic Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Pharma Ophthalmic Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa Pharma Ophthalmic Sales, (K Pcs), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Pharma Ophthalmic Product Offerings
Table 48. Novartis Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Allergan Corporate Summary
Table 50. Allergan Pharma Ophthalmic Product Offerings
Table 51. Allergan Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Roche Corporate Summary
Table 53. Roche Pharma Ophthalmic Product Offerings
Table 54. Roche Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Valeant Corporate Summary
Table 56. Valeant Pharma Ophthalmic Product Offerings
Table 57. Valeant Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Regeneron Corporate Summary
Table 59. Regeneron Pharma Ophthalmic Product Offerings
Table 60. Regeneron Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Santen Corporate Summary
Table 62. Santen Pharma Ophthalmic Product Offerings
Table 63. Santen Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Bayer Corporate Summary
Table 65. Bayer Pharma Ophthalmic Product Offerings
Table 66. Bayer Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Pharma Ophthalmic Product Offerings
Table 69. Pfizer Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Senju Corporate Summary
Table 71. Senju Pharma Ophthalmic Product Offerings
Table 72. Senju Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Akorn Corporate Summary
Table 74. Akorn Pharma Ophthalmic Product Offerings
Table 75. Akorn Pharma Ophthalmic Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Pharma Ophthalmic Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 77. Global Pharma Ophthalmic Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Pharma Ophthalmic Production by Region, 2017-2022 (K Pcs)
Table 79. Global Pharma Ophthalmic Production by Region, 2023-2028 (K Pcs)
Table 80. Pharma Ophthalmic Market Opportunities & Trends in Global Market
Table 81. Pharma Ophthalmic Market Drivers in Global Market
Table 82. Pharma Ophthalmic Market Restraints in Global Market
Table 83. Pharma Ophthalmic Raw Materials
Table 84. Pharma Ophthalmic Raw Materials Suppliers in Global Market
Table 85. Typical Pharma Ophthalmic Downstream
Table 86. Pharma Ophthalmic Downstream Clients in Global Market
Table 87. Pharma Ophthalmic Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pharma Ophthalmic Segment by Type
Figure 2. Pharma Ophthalmic Segment by Application
Figure 3. Global Pharma Ophthalmic Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pharma Ophthalmic Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pharma Ophthalmic Revenue, 2017-2028 (US$, Mn)
Figure 7. Pharma Ophthalmic Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Pharma Ophthalmic Revenue in 2021
Figure 9. By Type - Global Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 10. By Type - Global Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 11. By Type - Global Pharma Ophthalmic Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 13. By Application - Global Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 14. By Application - Global Pharma Ophthalmic Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 16. By Region - Global Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 17. By Country - North America Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 18. By Country - North America Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 19. US Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 24. Germany Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 25. France Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 33. China Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 37. India Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 39. By Country - South America Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 40. Brazil Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Pharma Ophthalmic Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Pharma Ophthalmic Sales Market Share, 2017-2028
Figure 44. Turkey Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Pharma Ophthalmic Revenue, (US$, Mn), 2017-2028
Figure 48. Global Pharma Ophthalmic Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production Pharma Ophthalmic by Region, 2021 VS 2028
Figure 50. Pharma Ophthalmic Industry Value Chain
Figure 51. Marketing Channels
